Understand Your Predisposition to Cancer

The Privy Health Hereditary Cancer Insight helps you understand how your genetic profile impacts your predisposition to 25 types of cancer.
Get Cancer Insight Now

Knowledge Is Power

Everyone is at risk of developing cancer, but what we do to lower our exposure will speak volumes when it comes to prevention and treatment. Some individuals are genetically predisposed to the development of certain types of cancers because they might run in his or her family. Genetic testing for hereditary cancer can present valuable medical information to you.

Preventative Action

Results let you work with your healthcare provider to explore lifestyle changes and make medically informed decisions to reduce your cancer risk. Genetic testing increases the chances for successful treatment and the probability of early detection, which strengthens cancer prevention and dramatically increases the rate of survival.

Proactive Care

If you are diagnosed with a disease, or if a family history of a disease is revealed through testing, understanding your genetics can help you make more informed treatment decisions. It can also provide insight into how particular predispositions may play a role within your family. That not only includes your children but siblings, aunts, and uncles, nieces and cousins.

Cancer Insight (CGX) Screening Includes

  • Information about the presence of genetic markers associated with an increased risk for cancer
  • An evaluation of your personal and family medical history
  • Individualized assessment of your cancer risk information and how your predisposition could affect your family

Presence of a Mutation and Increased Risk

The Privy Health Cancer Insight analyzes over 100 genes and tumor markers, including BRCA1, BRCA2, MLH1, and MSH2. A mutation in one or more of these genes can indicate an increased risk of cancer, including forms of breast, ovarian, colorectal, or prostate cancer.

Mutations found in your genes can considerably increase your risk of developing cancer. The graphs below show the risk for cancer types that correspond with mutations in the following genes: APC, CDH1, BRCA1, CDKN2A, MLH1, BRCA2 .

Women’s % of Risk 

In women, the presence of a BRCA1 mutation increase the chances of breast cancer up to 81% and ovarian cancer up to 54% by age 81.

Men’s % of Risk

In men, the presence of an APC mutation dramatically increase the probability of colorectal cancer up to 70-100% by age 80, if untreated.

Got Questions?